Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Iterative Health

Request full access

AI-powered clinical research site network

Cambridge, United StatesFounded 2017Health Tech & Medtech

About Iterative Health

Iterative Health, formerly Iterative Scopes, is a healthcare technology and services company that works to speed up clinical research by building a multispecialty network of research sites embedded in everyday clinical care. The company was spun out of the Massachusetts Institute of Technology in 2017 by founder and CEO Jonathan Ng, and it has headquarters in Cambridge, Massachusetts, and New York. It began by applying computer vision to gastrointestinal endoscopy and developed SKOUT, an FDA-cleared AI system that helps physicians detect polyps during colonoscopy.

Today the company's focus is on clinical trial execution. Iterative Health partners with physician practices and provider organisations and supports them with centralised operations, expert research staff, proprietary AI technology and clinical trial expertise, so that practices can run studies alongside patient care. The model uses AI to accelerate trial enrolment, addressing an industry where more than half of research sites enrol one or fewer patients per study and most trials miss their enrolment targets on time.

For pharmaceutical, biotech, medical device companies and contract research organisations, the network offers centralised access to a large group of experienced research sites and diverse patient populations. Iterative Health's global network includes more than 100 research sites across North America, Europe, India and Australia, and it works with more than 40 sponsor and CRO partners, with reported gains in site activation speed and patient enrolment rates in inflammatory bowel disease trials.

The company's roots are in gastroenterology and hepatology, where it collaborates with provider organisations such as GI Alliance and OneGI. It is expanding into further therapeutic areas, including cardiology through a partnership with U.S. Heart & Vascular, and obesity.

Source: Dealroom company data

Iterative Health in the Cambridge ecosystem

Live from Dealroom

The Iterative Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

18 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

Series A11 investors entered at this stage

Series B and later4 investors entered at this stage

Team profiled 24 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$854k

6 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Iterative Health on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.